Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
BörsenkürzelINMD
Name des UnternehmensInmode Ltd
IPO-datumAug 08, 2019
CEOMr. Moshe Mizrahy
Anzahl der mitarbeiter599
WertpapierartOrdinary Share
GeschäftsjahresendeAug 08
AddresseTavor Building, Sha'ar Yokneam
StadtYOKNEAM
BörseNASDAQ Global Select Consolidated
LandIsrael
Postleitzahl2069200
Telefon97249097470
Websitehttps://inmodemd.com/
BörsenkürzelINMD
IPO-datumAug 08, 2019
CEOMr. Moshe Mizrahy
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten